Two national pandemics – COVID-19 and racism – have highlighted inequities in medication use in the United States. These inequities often translate to poorer health outcomes in communities that already have barriers to optimal health. While the evidence documenting these disparities is abundant, systemic solutions remain elusive. This seminar will focus on #pharmacoequity and how pharmacists can help bring an end to health disparities.
The 28th Pharmaceutical Outcomes and Policy seminar will examine how optimal medication use differs by race and ethnicity and what underlying factors confound this relationship. Experts will discuss imperatives for increasing diversity in clinical trials, removing access barriers, and enhancing data and measures. Finally, industry leaders will share examples of incremental progress made through real-world programs and propose systemic strategies to combat racial inequities in medication use.
Location: Seminar will be held virtually this year – please register below.
Dates: March 5-6, 2022
When: 11 – 1:15 p.m.; 2:30 – 4 p.m. EST
Assistant Professor of Medicine University of Pittsburgh School of Medicine
Senior Fellow, University of Southern California (USC) Schaeffer Center
Hygeia Centennial Chair and Associate Professor, USC School of Pharmacy
Director, Policy, Research and Membership
Director, Division of Pharmacy
Center for Medicaid and CHIP
Center for Medicare and Medicaid Services
Director, Diversity & Patient Inclusion
Therapeutic Lead, Imbruvica and Solid Tumors
Professor and Vice Chair for Research
Department of Clinical Pharmacy and Translational Science
University of Tennessee College of Pharmacy
CEO, Pharmacy Quality Alliance
Associate Dean for Diversity, Inclusion and Health Equity
University of Florida, College of Pharmacy